Skip to main navigation
Skip to search
Skip to main content
Ulster University Home
Home
Researchers
Research units
Projects
Research output
Student theses
Datasets
Activities
Press/Media
Prizes
Search by expertise, name or affiliation
Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes
V Pathak,
Peter Flatt
,
Nigel Irwin
School of Biomedical Sciences
Faculty Of Life & Health Sciences
School of Pharm. & Pharmaceut. Sc.
Research output
:
Contribution to journal
›
Article
›
peer-review
58
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Cholecystokinin
100%
Beta Cell
12%
Satiety
12%
Glucagon Like Peptide 1
12%
Gut
12%
Central Nervous System
12%
Insulin Release
12%
Adjuvant Therapy
12%
Gastric Inhibitory Polypeptide
12%
Incretin
12%
Cell Function
12%
Body Weight Loss
12%
Cell Survival
12%
Leptin
12%
Cholecystokinin B Receptor
12%
Amylin
12%
Enteric Nervous System
12%
Cholecystokinin Derivative
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cholecystokinin
100%
Non Insulin Dependent Diabetes Mellitus
100%
Glucagon-Like Peptide-1
12%
Gastric Inhibitory Polypeptide
12%
Incretin
12%
Leptin
12%
Amylin
12%
Cholecystokinin Derivative
12%
Cholecystokinin B Receptor
12%